| pubmed-article:11009043 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C0004096 | lld:lifeskim |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C1708335 | lld:lifeskim |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C0001927 | lld:lifeskim |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C0060657 | lld:lifeskim |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C0205345 | lld:lifeskim |
| pubmed-article:11009043 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:11009043 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11009043 | pubmed:dateCreated | 2001-1-18 | lld:pubmed |
| pubmed-article:11009043 | pubmed:abstractText | To compare the relative systemic dose potency and tolerability of inhaled formoterol and salbutamol and to describe elimination of formoterol, particularly any enantioselectivity. | lld:pubmed |
| pubmed-article:11009043 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11009043 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11009043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11009043 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11009043 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:11009043 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:11009043 | pubmed:author | pubmed-author:PerssonGG | lld:pubmed |
| pubmed-article:11009043 | pubmed:author | pubmed-author:LarssonPP | lld:pubmed |
| pubmed-article:11009043 | pubmed:author | pubmed-author:LötvallJJ | lld:pubmed |
| pubmed-article:11009043 | pubmed:author | pubmed-author:BengtssonTT | lld:pubmed |
| pubmed-article:11009043 | pubmed:author | pubmed-author:RosenborgJJ | lld:pubmed |
| pubmed-article:11009043 | pubmed:author | pubmed-author:BlomgrenAA | lld:pubmed |
| pubmed-article:11009043 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11009043 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:11009043 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11009043 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11009043 | pubmed:pagination | 363-70 | lld:pubmed |
| pubmed-article:11009043 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:meshHeading | pubmed-meshheading:11009043... | lld:pubmed |
| pubmed-article:11009043 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11009043 | pubmed:articleTitle | Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. | lld:pubmed |
| pubmed-article:11009043 | pubmed:affiliation | Experimental Medicine, AstraZeneca R&D Lund, Sweden. Johan.Rosenborg@astrazeneca.com | lld:pubmed |
| pubmed-article:11009043 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11009043 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11009043 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11009043 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11009043 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11009043 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11009043 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11009043 | lld:pubmed |
